Course of erosive gastroesophageal reflux disease (ERD) - A prospective examination under therapeutic daily life conditions with a mean follow-up of 6.5 years

Zeitschrift fur Gastroenterologie

Volumn 44, Issue 10, 2006, Pages 1039-1042

  Hartmann, Dirk ^a   Kudis, V ^a   Jakobs, R ^a   Riemann, J F ^a   Schilling, D ^b  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b Diakoniekrankenhaus Mannheim   (Germany)

Author keywords

Barrett's esophagus; Esophageal cancer; GERD

Indexed keywords

ANTACID AGENT;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL FEATURE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; DRUG USE; ENDOSCOPY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SCREENING TEST;

ADULT; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ENDOSCOPY, GASTROINTESTINAL; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; MASS SCREENING; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33750910332     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-927089     Document Type: Article

References (14)

1. Devesa SS, Blot WJ, Fraumeni Jr JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-2053
2. Shaheen NJ, Crosby MA, Bozymski EM et al. Is there a publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 333-338
3. Sampliner RE. Practice Parameters Commitee of the American College of Gastroenterology: Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-1895
4. Madisch A, Hotz J, Londong W et al. Topic complex IV: Erosive reflux disease (ERD). Z Gastroenterol 2005; 43: 179-182
5. Corley DA, Levin TR, Habel LA et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 2002; 122: 633-640
6. Savary M, Miller G. The Esophagus. Textbook and Endoscopic Atlas. Solothurn, Gasman 1977: 135-142
7. Spechler SJ. Clinical practice. Barrett's esophagus. N Engl J Med 2002; 346: 836-842
8. El-Serag HB, Sonnenberg A. Association between different forms of gastro-oesophageal reflux disease. Gut 1997; 41: 594-599
9. Schindlbeck NE, Klauser AG, Berghammer G et al. Three year follow up of patients with gastro-oesophageal reflux disease. Gut 1992; 33: 1016-1019
10. Ashorn M, Ruuska T, Karikoski R et al. The natural course of gastroesophageal reflux disease in children. Scand J Gastroenterol 2002; 37: 638-641
11. Isolauri J, Luostarinen M, Isolauri E et al. Natural course of gastroesophageal reflux disease: 17-22 year follow up of 60 patients. Am J Gastroenterol 1997; 92: 37-41
12. McDougall NI, Johnston BT, Collins JS et al. Disease progression in gastro - oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis. Eur J Gastroenterol Hepatol 1997; 9: 1161-1167
13. Pace F, Santalucia F, Bianchi Porro G. Natural history of gastro-oesophageal reflux disease without oesophagitis. Gut 1991; 32: 845-848
14. Souza RF, Shewmake K, Terada LS et al. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 2002; 122: 299-307